CAPTRUST Financial Advisors
IRMD icon

CAPTRUST Financial Advisors’s iRadimed IRMD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-827
Closed -$28K – 3046
2022
Q2 		$28K Sell
827
-304
-27% -$10.9K ﹤0.01% 3171
2022
Q1 		$51K Hold
1,131
– – ﹤0.01% 2767
2021
Q4 		$52K Buy
1,131
+306
+37% +$12.3K ﹤0.01% 2635
2021
Q3 		$28K Buy
+825
New +$28.1K ﹤0.01% 2943
2021
Q1 		– Sell
-34,146
Closed -$779K – 4418
2020
Q4 		$779K Buy
34,146
+1,014
+3% +$23.4K 0.01% 685
2020
Q3 		$711K Buy
33,132
+10,264
+45% +$231K 0.01% 612
2020
Q2 		$543K Buy
22,868
+935
+4% +$20.1K 0.01% 680
2020
Q1 		$436K Buy
+21,933
New +$522K 0.01% 622

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CAPTRUST Financial Advisors's IRMD Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of iRadimed (IRMD) in Q3 2022, closing a stake of 827 shares — an estimated $28K sold.

CAPTRUST Financial Advisors first reported a position in IRMD in Q1 2020 and held it in 8 quarters. The position peaked at $779K in Q4 2020. 86 funds tracked by Wall St. Rank hold IRMD as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining iRadimed position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 827 iRadimed shares in Q3 2022, an estimated $28K.
  • CAPTRUST Financial Advisors first reported a position in iRadimed in Q1 2020 and held it in 8 quarters.
  • CAPTRUST Financial Advisors's iRadimed position peaked at $779K in Q4 2020.
  • 86 funds tracked by Wall St. Rank held iRadimed as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.